Clinical trial NCT05946083: The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning
Official title: The Brain, the Bug, and the Binge: a Double-blind, Randomized Controlled Trial Investigating the Interplay Between Binge Drinking, Gut Microbiota and Brain Functioning
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: PHASE2
Conditions: Binge Drinking
Keywords: Adolescence
Young Adulthood
Alcohol
Binge Drinking
Gut Microbiome
Microbiota-Gut-Brain Axis
Magnetic Resonance Imaging
Pro-inflammatory cytokines
Psychobiotics
Randomized Controlled Trial
Lead sponsor: University of Minho
Sponsor class: OTHER
Collaborators: name: Foundation for Science and Technology, Portugal
First posted: 2023-07-14
Enrollment: 82
Sex: ALL
Minimum age (years): 18
Maximum age (years): 23
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Binge Drinkers will be randomly distributed for one of two groups: 23 subjects with inulin intervention and 23 subjects with maltodextrin intervention (\~50 % male and \~50 % female in each group).

There will also be a non-interventional control group consisting of 36 non/low-drinkers.
Primary purpose: PREVENTION

Brief summary: Adolescence and youth are periods of significant maturational changes which seems to involve greater susceptibility to disruptive events in the brain such as binge drinking (BD). This prevalent pattern of consumption -characterized by repeated alcohol intoxications- is of special concern, as it has been associated with major neurocognitive impairments in the young brain.

Recent studies indicate that alcohol may disrupt the gut microbiota (GM) and that these disruptions may lead to impairments in brain and behavior. Also, interventions with psychobiotics have been shown to result in reductions in alcohol-induced damage and in improvements on cognitive and brain functioning.

Thus, the present proposal will explore the effects of BD on GM. Additionally, a GM intervention with psychobiotics both in-vivo and in-vitro, will determine whether improvements in GM composition/function may lead to reductions of alcohol-induced brain damage in BD-population, a barely unexplored research field with major clinical applications.

Detailed description: The present study protocol aims to determine the interaction between alcohol consumption, brain function and gut microbiota through several levels of analysis, including techniques to measure brain activity (i.e., magnetic resonance imaging), paradigms to measure cognitive performance, collection of stool and blood samples, and questionnaires. Additionally, this study will investigate the relationship between alcohol, brain activity and gut microbiota and how this can be modified through our diet. The sample will be composed by a cohort of young college students (18-23 years) from the University of Minho (UM; Braga, Portugal) selected according to their drinking patterns. Eighty-two participants will be recruited from UM: 36 non/low-drinkers and 46 binge drinkers (BDs) matched for age and gender. Recruitment will be carried out through an online survey broadcasted using the institutional email. This survey will include a simple sociodemographic section and items regarding the use of alcohol (Alcohol Use Disorder Identification Test - AUDIT, frequency of alcohol consumption, number of drinks consumed on each day of the past week, speed of drinking, etc.). After sample selection, participants will be submitted to the following steps: (1) clinical interview - addresses questions relating to psychological, medical, personal and family history, including questions related to history of alcohol and drug use and some specific questionnaires relating to substance use, as well as those related to physical and psychological symptoms, and personality; (2) neuroimaging assessment - will consist of a structural and functional magnetic resonance imaging (fMRI) at the Hospital de Guimarães (Portugal), while performing different cognitive tasks; (3) evaluation of some microorganisms residing in the gut and certain inflammatory markers - each participant will be asked to collect stool and blood samples; (4) evaluation of the potential of an intervention with psychobiotics.

Thus, this protocol involves the following phases:

1. pre-intervention, consisting of the assessment of the variables of interest to the study by means of a clinical interview, neuropsychological testing, collection of stool and blood samples, and MRI recordings.
2. intervention (only for BDs), consisting of taking a prebiotic for 6 weeks. Depending on the group to which they will be allocated, the participant will take one of two types of fiber: a fiber with benefits for intestinal bacteria (inulin) or a similar fiber with no specific benefits for the intestinal microbiome (maltodextrin). Each participant will not know which group they belong to in order not to bias the results of the study according to scientific standards.
3. post-intervention, which will consist in the re-assessment of the variables previously assessed in the pre-intervention phase.
4. follow-up, consisting of the assessment and monitoring of levels of alcohol consumption and craving during the 3 months following the intervention phase.

Eligibility criteria: Inclusion Criteria:

* College students whose native language is Portuguese;
* Age 18-23 years;
* Binge Drinkers: report (i) drinking 4 (for women)/5 (for men) or more drinks on one occasion at least once a month, (ii) drinking at a speed of at least two drinks per hour during these episodes (which brings blood alcohol concentration to 0.08 g/dL or above), and (iii) having an AUDIT score \< 20.
* Non/Low-Drinkers: report (i) never drinking 4/5 or more drinks on one occasion and (ii) having an AUDIT score ≤ 4.

Exclusion Criteria:

* Use of illicit drugs as determined by the Drug Use Disorders Identification Test (DUDIT);
* Alcohol abuse (i.e., AUDIT ≥ 20);
* Personal history of psychopathological disorders (according to DSM-V criteria);
* History of traumatic brain injury or neurological disorder;
* Family history (mother/father) of alcoholism diagnosis of substance abuse;
* Occurrence of one or more episodes of loss of consciousness for more than 30 minutes;
* Non-corrected sensory deficits;
* Diagnosis of any gut disease/problems or other medical conditions: inflammatory bowel disease, irritable bowel syndrome, Crohn's Disease, celiac disease, lactose intolerance, autoimmune disease;
* Consumption of medical drugs with psychoactive effects (e.g., antidepressants, anxiolytics or benzodiazepines) during the 4 weeks prior to the experiment;
* Use of any of the following drugs in the last 4 weeks: laxatives, antibiotics, anticoagulants, non-steroidal anti-inflammatory drugs, analgesics, corticosteroids;
* No type of metal object implanted in the body, especially in the head (orthodontic appliances are not excluded).

Primary outcomes:
measure: Alcohol Consumption - Drinking pattern
timeFrame: Screening visit (clinical interview)
measure: Alcohol Consumption - Drinking pattern
timeFrame: At baseline (pre-intervention)
measure: Alcohol Consumption - Drinking pattern
timeFrame: Immediately post-intervention
measure: Alcohol Consumption - Drinking pattern
timeFrame: 3 months post-intervention
measure: Alcohol Craving - Short-term acute craving
timeFrame: Screening visit (clinical interview)
measure: Alcohol Craving - Short-term acute craving
timeFrame: At baseline (pre-intervention)
measure: Alcohol Craving - Short-term acute craving
timeFrame: Immediately post-intervention
measure: Alcohol Craving - Short-term acute craving
timeFrame: 3 months post-intervention
measure: Use of illicit drugs
timeFrame: Screening visit (clinical interview)
measure: Description of Food Frequency
timeFrame: Screening visit (clinical interview)
measure: Food Diary
timeFrame: Intervention (6 weeks)
measure: Impulsivity Assessment
timeFrame: Screening visit (clinical interview)
measure: Impulsivity Assessment
timeFrame: 3 months post-intervention
measure: Neuropsychological Evaluation - Memory
timeFrame: At baseline (pre-intervention)
measure: Neuropsychological Evaluation - Memory
timeFrame: Immediately post-intervention
measure: Neuropsychological Evaluation - Emotion and Social Cognition
timeFrame: At baseline (pre-intervention)
measure: Neuropsychological Evaluation - Emotion and Social Cognition
timeFrame: Immediately post-intervention
measure: Neuropsychological Evaluation - Executive Function
timeFrame: At baseline (pre-intervention)
measure: Neuropsychological Evaluation - Executive Function
timeFrame: Immediately post-intervention
measure: Alcohol Cue Reactivity - Emotional measures
timeFrame: At baseline (pre-intervention)
measure: Alcohol Cue Reactivity - Emotional measures
timeFrame: Immediately post-intervention.
measure: Memory Inhibition Performance
timeFrame: At baseline (pre-intervention)
measure: Memory Inhibition Performance
timeFrame: Immediately post-intervention.
measure: Ability of Emotional Recognition
timeFrame: At baseline (pre-intervention)
measure: Ability of Emotional Recognition
timeFrame: Immediately post-intervention.
measure: Fecal Microbiota - Species Richness
timeFrame: At baseline (pre-intervention)
measure: Fecal Microbiota - Species Richness
timeFrame: Immediately post-intervention.
measure: Fecal Microbiota - Species Diversity
timeFrame: At baseline (pre-intervention)
measure: Fecal Microbiota - Species Diversity
timeFrame: Immediately post-intervention.
measure: Fecal Microbiota - Quantification of SCFAs levels
timeFrame: At baseline (pre-intervention)
measure: Fecal Microbiota - Quantification of SCFAs levels
timeFrame: Immediately post-intervention.
measure: Blood samples - Presence of Inflammatory Markers
timeFrame: At baseline (pre-intervention)
measure: Blood samples - Presence of Inflammatory Markers
timeFrame: Immediately post-intervention.
Secondary outcomes:
Other outcomes:
Locations:
city: Braga
country: Portugal
facility: Psychological Neuroscience Laboratory, Psychology Research Center, University of Minho
state: Gualtar, Braga
Study officials:
affiliation: Psychological Neuroscience Laboratory, Psychology Research Center, University of Minho, Portugal.
name: Eduardo G. López-Caneda, PhD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Carbia C, Bastiaanssen TFS, Iannone LF, Garcia-Cabrerizo R, Boscaini S, Berding K, Strain CR, Clarke G, Stanton C, Dinan TG, Cryan JF. The Microbiome-Gut-Brain axis regulates social cognition & craving in young binge drinkers. EBioMedicine. 2023 Mar;89:104442. doi: 10.1016/j.ebiom.2023.104442. Epub 2023 Feb 2.
citation: Sousa SS, Sampaio A, Marques P, Lopez-Caneda E, Goncalves OF, Crego A. Functional and structural connectivity of the executive control network in college binge drinkers. Addict Behav. 2019 Dec;99:106009. doi: 10.1016/j.addbeh.2019.05.033. Epub 2019 Jun 3.
citation: Almeida-Antunes N, Crego A, Carbia C, Sousa SS, Rodrigues R, Sampaio A, Lopez-Caneda E. Electroencephalographic signatures of the binge drinking pattern during adolescence and young adulthood: A PRISMA-driven systematic review. Neuroimage Clin. 2021;29:102537. doi: 10.1016/j.nicl.2020.102537. Epub 2020 Dec 17.
citation: White A, Hingson R. The burden of alcohol use: excessive alcohol consumption and related consequences among college students. Alcohol Res. 2013;35(2):201-18.
citation: Carbia C, Lannoy S, Maurage P, Lopez-Caneda E, O'Riordan KJ, Dinan TG, Cryan JF. A biological framework for emotional dysregulation in alcohol misuse: from gut to brain. Mol Psychiatry. 2021 Apr;26(4):1098-1118. doi: 10.1038/s41380-020-00970-6. Epub 2020 Dec 7.
citation: Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701-12. doi: 10.1038/nrn3346. Epub 2012 Sep 12.
citation: Cryan JF, O'Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol. 2020 Feb;19(2):179-194. doi: 10.1016/S1474-4422(19)30356-4. Epub 2019 Nov 18.
citation: Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Starkel P, Windey K, Tremaroli V, Backhed F, Verbeke K, de Timary P, Delzenne NM. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93. doi: 10.1073/pnas.1415174111. Epub 2014 Oct 6.
citation: Leclercq S, de Timary P, Delzenne NM, Starkel P. The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Transl Psychiatry. 2017 Feb 28;7(2):e1048. doi: 10.1038/tp.2017.15.
citation: Jadhav KS, Peterson VL, Halfon O, Ahern G, Fouhy F, Stanton C, Dinan TG, Cryan JF, Boutrel B. Gut microbiome correlates with altered striatal dopamine receptor expression in a model of compulsive alcohol seeking. Neuropharmacology. 2018 Oct;141:249-259. doi: 10.1016/j.neuropharm.2018.08.026. Epub 2018 Aug 31.
citation: Leclercq S, Starkel P, Delzenne NM, de Timary P. The gut microbiota: A new target in the management of alcohol dependence? Alcohol. 2019 Feb;74:105-111. doi: 10.1016/j.alcohol.2018.03.005. Epub 2018 Mar 20.
citation: Lannoy S, Billieux J, Dormal V, Maurage P. Behavioral and Cerebral Impairments Associated with Binge Drinking in Youth: A Critical Review. Psychol Belg. 2019 Mar 29;59(1):116-155. doi: 10.5334/pb.476.
citation: Lopez-Caneda E, Crego A, Campos AD, Gonzalez-Villar A, Sampaio A. The Think/No-Think Alcohol Task: A New Paradigm for Assessing Memory Suppression in Alcohol-Related Contexts. Alcohol Clin Exp Res. 2019 Jan;43(1):36-47. doi: 10.1111/acer.13916. Epub 2018 Nov 25.